|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
(b)(4) (rep, hcp, for): information was received from healthcare provider (hcp) via a manufacturer representative regarding an event which occurred during a l1 transcutaneous vertebroplasty procedure in a patient diagnosed with compression fracture due to primary osteoporosis.Patient medical history: hypertension, hyperlipidemia, appendicitis, cataract, cerebral infarction, bronchial asthma.It was reported that when the balloon was inserted and inflated, it ruptured at 310psi.There was no patient symptom reported.There were no further complications reported regarding the event.
|